French startup Pixii has been making rangefinder cameras with Leica M mounts since 2018, but the new Max is its first with a ...

French camera maker Pixii has announced the Pixii Max, a 24MP full-frame rangefinder camera that accepts Leica M-mount lenses ...

Norwegian battery producer Pixii has unveiled Pixii Home, a modular battery for residential applications. “Pixii has grown rapidly based on its reputation as a supplier of high-quality energy ...

At Least 9 Killed as Israel Begins Major Military Operation in West Bank Hundreds of troops entered cities in the occupied territory, targeting Palestinian militants. It was a significant ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

On a trip to Germany, Prime Minister Keir Starmer exchanged warm words with Germany’s chancellor, Olaf Scholz. But a reset with the European Union will depend on actions too. By Stephen Castle ...

Researchers have identified two distinct mechanisms of drug resistance in C. difficile, but its ability to withstand antibiotics comes with downsides for the bacteria. Scientists are trying to ...

MATTHEW LAMBERT AT FLUSHING MEADOWS: Emma Raducanu tearfully admitted she will look to 'manage my schedule differently' after she was beaten in the first round of the US Open by Sofia Kenin - her ...

The startup also offers its energy customers the ability to install a home battery (it currently resells the Pixii Home) so they can store energy for later use. This enables households to respond ...

The second describes magneto-electric machines beginning with that of Pixii and ending with that of De Meritens. The third chapter, on dynamo-electric machines, opens with a rather unseemly ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.

Aug. 22, 2024 — The researchers looked at data from 4,286 people -- out of a total of 17,605 from the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial who were randomly assigned ...